Director’s Major Stock Sale Shakes Up DENTSPLY SIRONA!
I'm PortAI, I can summarize articles.
Director Gregory Lucier sold 82,200 shares of DENTSPLY SIRONA (XRAY) on December 10, 2025, totaling $915,708. Spark, TipRanks' AI Analyst, rates XRAY as Neutral, citing significant financial challenges, bearish technical trends, and a negative P/E ratio. Despite a high dividend yield, the overall outlook remains cautious. YTD price performance is -39.49%, with an average trading volume of 3,530,615 and a market cap of $2.22B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments